Much of TRIM-edicine's technology remains proprietary while other studies have appears in several peer-reviewed publications. A sample of some of these papers appears below: 

Wang X, Weisleder N, Collet C, Zhou J, Chu Y, Hirata Y, Zhao X, Pan Z, Brotto M, Cheng H, Ma J. Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle. Nat Cell Biol. 2005 May;7(5):525-30.

Weisleder N, Brotto M, Komazaki S, Pan Z, Zhao X, Nosek T, Parness J, Takeshima H, Ma J. Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J Cell Biol. 2006 Aug 28;174(5):639-45.

Ko JK, Choi KH, Pan Z, Lin P, Weisleder N, Kim CW, Ma J. The tail-anchoring domain of Bfl1 and HCCS1 targets mitochondrial membrane permeability to induce apoptosis. J Cell Sci. 2007 Aug 15;120(Pt 16):2912-23.

Weisleder N, Takeshima H, Ma J. Immuno-proteomic approach to excitation--contraction coupling in skeletal and cardiac muscle: molecular insights revealed by the mitsugumins. Cell Calcium. 2008 Jan;43(1):1-8. Review.

For reprints or questions please contact us (info@trim-edicine.com)

TRIM-edicine, Inc.
Commercialization Center for Innovative Technology
Suite 126
675 US Highway 1
North Brunswick, NJ 08902
(732)729-6255
info@trim-edicine.com